Developing strategies for liver fibrosis treatment

Author： Murphy Frank Arthur Michael Iredale John

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.11, Iss.11, 2002-11, pp. : 1575-1585

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Liver Fibrosis and Therapeutic Strategies: The Goal for Improving Metabolism

Current Drug Targets, Vol. 10, Iss. 6, 2009-06 ,pp. : 505-512

Bentham Science Publishers

Access to resources Recommend Favorite

Hepatic PPARs: Their Role in Liver Physiology, Fibrosis and Treatment

Current Medicinal Chemistry, Vol. 20, Iss. 27, 2013-09 ,pp. : 3370-3396

Bentham Science Publishers

Access to resources Recommend Favorite

Treatment strategies for cystic fibrosis: what's in the pipeline?

By Frerichs Carley Smyth Alan

Expert Opinion on Pharmacotherapy, Vol. 10, Iss. 7, 2009-05 ,pp. : 1191-1202

Informa Healthcare

Access to resources Recommend Favorite

Modulation of thioacetamide-induced liver fibrosis/cirrhosis by sildenafil treatment

By Said Shehta A. Gameil Nariman M. Ammar Elsayed M.

Canadian Journal of Physiology and Pharmacology, Vol. 91, Iss. 12, 2013-01 ,pp. : 1055-1063

NRC Research Press

Access to resources Recommend Favorite

Halofuginone for liver fibrosis prevention and treatment?

Inpharma, Vol. 1, Iss. 1279, 2001-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite